Cargando…

Blocking the formation of radiation–induced breast cancer stem cells

The goal of adjuvant (post-surgery) radiation therapy (RT) for breast cancer (BC) is to eliminate residual cancer cells, leading to better local tumor control and thus improving patient survival. However, radioresistance increases the risk of tumor recurrence and negatively affects survival. Recent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yangyang, Li, Wende, Patel, Shalin S., Cong, Juan, Zhang, Nan, Sabbatino, Francesco, Liu, Xiaoyan, Qi, Yuan, Huang, Peigen, Lee, Hang, Taghian, Alphonse, Li, Jian-Jian, DeLeo, Albert B., Ferrone, Soldano, Epperly, Michael W., Ferrone, Cristina R., Ly, Amy, Brachtel, Elena F., Wang, Xinhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4116517/ https://www.ncbi.nlm.nih.gov/pubmed/25003837

Ejemplares similares

Expression status of folate receptor alpha is a predictor of survival in pancreatic ductal adenocarcinoma
por: Cai, Lei, et al.
Publicado: (2017)

High TIL, HLA, and Immune Checkpoint Expression in Conventional High-Grade and Dedifferentiated Chondrosarcoma and Poor Clinical Course of the Disease
por: Nota, Sjoerd P. F. T., et al.
Publicado: (2021)

Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and tumor microenvironment, overcoming multiple obstacles of CAR T therapy for solid tumors
por: Wang, Yufeng, et al.
Publicado: (2023)

PDGFRα up-regulation mediated by sonic hedgehog pathway activation leads to BRAF inhibitor resistance in melanoma cells with BRAF mutation
por: Sabbatino, Francesco, et al.
Publicado: (2014)

Chondroitin sulfate proteoglycan 4 expression in chondrosarcoma: A potential target for antibody-based immunotherapy
por: Nota, Sjoerd P. F. T., et al.
Publicado: (2022)

Correction to: Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram
por: Sun, Ting, et al.
Publicado: (2020)

Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram
por: Sun, Ting, et al.
Publicado: (2020)

B7-H3-targeted CAR T cell activity is enhanced by radiotherapy in solid cancers
por: Ventin, Marco, et al.
Publicado: (2023)

Harnessing host innate immunity may combat acquired resistance to BRAFi
por: Tan, Thomas, et al.
Publicado: (2014)

Ipilimumab in the treatment of metastatic melanoma: management of adverse events
por: Della Vittoria Scarpati, Giuseppina, et al.
Publicado: (2014)

Resistance to anti-PD-1-based immunotherapy in basal cell carcinoma: a case report and review of the literature
por: Sabbatino, Francesco, et al.
Publicado: (2018)

Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironment
por: Wang, Yufeng, et al.
Publicado: (2023)

Overexpression of miR-489 enhances efficacy of 5-fluorouracil-based treatment in breast cancer stem cells by targeting XIAP
por: Wang, Xuedong, et al.
Publicado: (2017)

ADAM12-L confers acquired 5-fluorouracil resistance in breast cancer cells
por: Wang, Xuedong, et al.
Publicado: (2017)

Grp94-specific monoclonal antibody to counteract BRAF inhibitor resistance in BRAF(V600E) melanoma
por: Sabbatino, F, et al.
Publicado: (2015)

Turning anecdotal irradiation-induced anti-cancer immune responses into reproducible in situ cancer vaccines via disulfiram/copper-mediated enhanced immunogenic cell death of breast cancer cells
por: Wang, Xinhui, et al.
Publicado: (2023)

Disulfiram Acts as a Potent Radio-Chemo Sensitizer in Head and Neck Squamous Cell Carcinoma Cell Lines and Transplanted Xenografts
por: Yao, Wenhao, et al.
Publicado: (2021)

Rewarding patient-directed research: Excellence in Translational Medicine Award
por: Brander, Christian, et al.
Publicado: (2006)

A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal adenocarcinoma
por: Liu, Zhenyang, et al.
Publicado: (2020)

Chondroitin Sulfate Proteoglycan-4 (CSPG4)-Specific Monoclonal Antibody 225.28 in Detection of Acute Myeloid Leukemia Blasts
por: Fenton, Moon, et al.
Publicado: (2015)

Selective Histocompatibility Leukocyte Antigen (Hla)-A2 Loss Caused by Aberrant Pre-mRNA Splicing in 624mel28 Melanoma Cells
por: Wang, Zhigang, et al.
Publicado: (1999)

Lost in Translation: Obstacles to Translational Medicine
por: Mankoff, Stacey P, et al.
Publicado: (2004)

Cancer Stem Cells Are Possible Key Players in Regulating Anti-Tumor Immune Responses: The Role of Immunomodulating Molecules and MicroRNAs
por: Tomei, Sara, et al.
Publicado: (2021)

Computationally Guided Design of Single-Chain Variable Fragment Improves Specificity of Chimeric Antigen Receptors
por: Krokhotin, Andrey, et al.
Publicado: (2019)

EGFR-mediated tumor immunoescape: The imbalance between phosphorylated STAT1 and phosphorylated STAT3
por: Concha-Benavente, Fernando, et al.
Publicado: (2013)

STAT1 contributes to HLA class I upregulation and CTL reactivity after anti-EGFR mAb cetuximab therapy in head and neck cancer patients
por: Srivastava, Raghvendra M, et al.
Publicado: (2013)

HLA class I downregulation is associated with enhanced NK‐cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors
por: Sottile, Rosa, et al.
Publicado: (2015)

Melanoma cell-derived exosomes in plasma of melanoma patients suppress functions of immune effector cells
por: Sharma, Priyanka, et al.
Publicado: (2020)

CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma
por: Maggs, Luke, et al.
Publicado: (2021)

Peritumoral Immune Infiltrate as a Prognostic Biomarker in Thin Melanoma
por: Sabbatino, Francesco, et al.
Publicado: (2020)

Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma
por: Mehta, Akash M., et al.
Publicado: (2007)

IRX-2, a Novel Immunotherapeutic, Enhances Functions of Human Dendritic Cells
por: Schilling, Bastian, et al.
Publicado: (2013)

Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell mediated lysis of prostate and breast carcinoma cells
por: Gameiro, Sofia R., et al.
Publicado: (2016)

Association of Tumor Cell Metabolic Subtype and Immune Response With the Clinical Course of Hepatocellular Carcinoma
por: Wei, Xiaolin, et al.
Publicado: (2023)

Adoptively transferred human lung tumor specific cytotoxic T cells can control autologous tumor growth and shape tumor phenotype in a SCID mouse xenograft model
por: Oflazoglu, Ezogelin, et al.
Publicado: (2007)

VARIATION IN SUSCEPTIBILITY OF A HUMAN LYMPHOID CELL LINE TO IMMUNE LYSIS DURING THE CELL CYCLE : LACK OF CORRELATION WITH ANTIGEN DENSITY AND COMPLEMENT BINDING
por: Pellegrino, Michele A., et al.
Publicado: (1974)

High frequency of HLA class I antigen processing machinery (APM) component upregulation in primary hepatocellular carcinoma tumors
por: Grizzi, Fabio, et al.
Publicado: (2013)

The Humoral Theory of Transplantation
por: Ravindranath, Mepur H., et al.
Publicado: (2017)

Canine Melanoma Immunology and Immunotherapy: Relevance of Translational Research
por: Tarone, Lidia, et al.
Publicado: (2022)

Differential role of HLA-A and HLA-B, C expression levels as prognostic markers in colon and rectal cancer
por: Michelakos, Theodoros, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_96674ljq7hcsve5s4qc2gi406c